Cases & Deals

Faron Pharmaceuticals completes IPO on AIM

Clients Faron Pharmaceuticals Oy

Jones Day advised Faron Pharmaceuticals Oy, a clinical stage biopharmaceutical company based in Turku, Finland, in connection with its initial public offering of Ordinary Shares on the Alternative Investment Market (AIM). Cairn Financial Advisors acted as nominated advisor and Whitman Howard Limited acted as nominated broker.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.